Cooperative Agreement NU3HCK000008

Summary of Federal Cooperative Agreement Award The Centers for Disease Control and Prevention (CDC), through its Center for Global Health, awarded a $100,000 Cooperative Agreement to Indonesia's Ministry of Health (Kementerian Kesehatan Republik Indonesia) on September 30, 2025, under the CDC Investigations and Technical Assistance program (CFDA 93.283). The five-year award, with an ultimate completion date of September 29, 2030, supports activities aimed at strengthening Indonesia's public...

This $1,000,000 five-year Project Grant was awarded on June 24, 2024 by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program. The grant will be used by the Indonesia One Health University Network (Indohun) to strengthen multi-sectoral systems to reduce the occurrence and impact of emerging infectious diseases (EIDs) in Indonesia through two key outcomes: 1) Improving the sharing and utilization of One Health data...

This Project Grant award from the National Science Foundation's Integrative Activities (IA) program provides $275,000 to Clemson University to develop a flexible, tunable voltammetric sensor that can rapidly detect and quantify virulence signals from the Pseudomonas aeruginosa bacteria. The goal is to enable faster determination of infections caused by antibiotic-resistant bacteria, which annually lead to more than 35,000 deaths in the U.S. despite widespread antibiotic availability. The...

This Cooperative Agreement award, provided by the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025), aims to utilize and expand antimicrobial resistance (AMR) analytics, predictive modeling, and forecasting tools and dashboards developed during a previous project. The primary purpose is to enhance the understanding of AMR dynamics and frequencies in microbial populations,...

This $991,832 Cooperative Agreement awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of a novel rapid antibiotic susceptibility testing (AST) platform by Astek Diagnostics Inc., a minority-owned small business in Halethorpe, Maryland. The project aims to adapt the company's previously developed urine cartridge technology for use with cerebrospinal fluid and wound effluent specimens, characterize...

This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award of $984,381 to Cobio Diagnostics Inc. in Aurora, Colorado aims to expand a diagnostic tool that enables rapid, direct-from-specimen identification and antimicrobial susceptibility testing of major bloodborne bacterial pathogens. The project will develop a regulatory pathway for FDA clearance, characterize antibodies to expand the test, and validate the expanded tests...

This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 aims to develop a platform for detecting genetic antibiotic resistance motifs that can predict current and future susceptibility to therapeutics. The project will establish the feasibility of leveraging mutational signatures in bacterial DNA to identify antibiotic resistance status, including the potential for rapid development of multi-drug resistance. This approach...

Federal Cooperative Agreement Summary The Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention awarded a $8.73 million Cooperative Agreement to the Association of Public Health Laboratories, Inc. (APHL) effective July 1, 2025, through June 30, 2030, under the Project Grants and Cooperative Agreements for Tuberculosis Control Programs (CFDA 93.116). This award supports the enhancement of public health laboratory capabilities and...

This $389,782 Cooperative Agreement award from the United States Department of Agriculture's Animal and Plant Health Inspection Service (APHIS), under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025), aims to develop highly specific and validated TaqMan assays for the simultaneous detection of two critical shrimp diseases: Hepatopancreatic Microsporidiosis (HPM) caused by Enterocytozoon hepatopenaei (EHP) and Acute Hepatopancreatic Necrosis Disease (AHPND) caused...

Project Grant Summary Brigham and Women's Hospital received a $198,630 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025, through July 31, 2030. This award supports the development and validation of BADLOCK, a CRISPR-based diagnostic assay designed to rapidly identify bacterial species and antimicrobial resistance (AMR) genes from blood cultures in...